Barry Kapik

Barry Kapik is a seasoned professional in biostatistics with extensive experience in the pharmaceutical and biotechnology industries. Currently serving as Senior Director of Biostatistics at Clearside Biomedical, Inc. since September 2018, Barry oversees all biostatistical activities and represents the company in discussions with FDA and other international health authorities regarding registration. Prior to this role, Barry held similar senior positions at Alimera Sciences, focusing on biostatistics, statistical programming, and medical writing for clinical trials. With a background that includes positions at Clinimetrics Research Associates, Inhibitex, StatWorks, Novartis Ophthalmics, Solvay Pharmaceuticals, and Trilogy Consulting, Barry has built a robust career starting from a statistician role and progressing to senior leadership in biostatistics. Barry holds an MS in Biostatistics and a BS in Statistics from Western Michigan University.